LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 20.01 | 21.74 | 1507 | 901 | 1.6709 | 1.2004 | MN20160310_N01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 21.98 | 21.74 | 1413 | 1108 | 1.2749 | 1.0875 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 21.98 | 21.74 | 1447 | 1108 | 1.3055 | 1.0963 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 21.98 | 21.74 | 1042 | 1108 | 0.9401 | 0.9784 | MN20160310_N01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 21.98 | 21.74 | 1601 | 1108 | 1.4445 | 1.1340 | MN20160310_N01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 23.95 | 21.74 | 1508 | 1354 | 1.1133 | 1.0363 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 23.95 | 21.74 | 1542 | 1354 | 1.1384 | 1.0440 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 23.95 | 21.74 | 1314 | 1354 | 0.9701 | 0.9898 | MN20160310_N01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 23.95 | 21.74 | 1665 | 1354 | 1.2292 | 1.0704 | MN20160310_N01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 25.92 | 21.74 | 1554 | 1515 | 1.0253 | 1.0082 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 25.92 | 21.74 | 1577 | 1515 | 1.0405 | 1.0130 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 25.92 | 21.74 | 1528 | 1515 | 1.0082 | 1.0027 | MN20160310_N01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 25.92 | 21.74 | 1787 | 1515 | 1.1790 | 1.0545 | MN20160310_N01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 27.89 | 21.74 | 1598 | 1677 | 0.9529 | 0.9847 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 27.89 | 21.74 | 1624 | 1677 | 0.9684 | 0.9898 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 27.89 | 21.74 | 1681 | 1677 | 1.0024 | 1.0008 | MN20160310_N01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 27.89 | 21.74 | 1859 | 1677 | 1.1085 | 1.0331 | MN20160310_N01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 29.86 | 21.74 | 1703 | 1887 | 0.9025 | 0.9684 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 29.86 | 21.74 | 1731 | 1887 | 0.9173 | 0.9734 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 29.86 | 21.74 | 1929 | 1887 | 1.0223 | 1.0068 | MN20160310_N01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 29.86 | 21.74 | 2035 | 1887 | 1.0784 | 1.0236 | MN20160310_N01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 31.83 | 21.74 | 1847 | 2110 | 0.8754 | 0.9601 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 31.83 | 21.74 | 1872 | 2110 | 0.8872 | 0.9641 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 31.83 | 21.74 | 2040 | 2110 | 0.9668 | 0.9898 | MN20160310_N01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 31.83 | 21.74 | 2197 | 2110 | 1.0412 | 1.0123 | MN20160310_N01 | N08 |